Research Article
A Five-Gene Expression Signature Predicts Clinical Outcome of Ovarian Serous Cystadenocarcinoma
Table 1
Assignment of patient demographic and clinical characteristics.
| Characteristic | Patients | Training set | Testing set | Total |
| Age at diagnosis (years) | | | | Median | 57 | 59 | 58 | Range | 34–87 | 30–87 | 30–87 | Vital status | | | | Living | 58 | 62 | 120 | Dead | 110 | 73 | 183 | Follow-up (days) | | | | Median | 1018 | 883 | 949 | Median (dead) | 1155 | 919 | 1069 | Clinical stage | | | | Stage I | 0 | 1 | 1 | Stage II | 8 | 13 | 21 | Stage III | 142 | 99 | 241 | Stage IV | 18 | 20 | 38 | Unknown | 0 | 2 | 2 |
|
|